Gloucester Pharma Raises $29 Million

Gloucester Pharmaceuticals, a Cambridge, Mass.-based developer of oncology drugs, has raised $29 million in Series D funding. Novo AS led the round, and was joined by return backers Apple Tree Partners, ProQuest Investments, Prospect Venture Partners and Rho Ventures. The company had previously raised over $100 million.

North AmericaUSBriefs